Literature DB >> 11053007

Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability.

D M McKay1, F Botelho, P J Ceponis, C D Richards.   

Abstract

Signal transducers and activators of transcription (STATs) are critical intracellular signaling molecules for many cytokines. We compared the ability of T84 epithelial cells to activate STATs in response to cytokines [interferon-gamma (IFN-gamma), interleukin (IL)-4, IL-10, and tumor necrosis factor-alpha (10 ng/ml)] and conditioned medium from superantigen [Staphylococcus aureus enterotoxin B (SEB)]-activated peripheral blood mononuclear cells (PBMC) using electrophoretic mobility shift assays (EMSA). Of the cytokines tested, only IFN-gamma caused a STAT-1 response. Exposure to SEB-PBMC-conditioned medium resulted in STAT-1 or STAT-1/3 activation, and inclusion of anti-IFN-gamma antibodies in the conditioned medium abolished the STAT-1 signal. Cells treated with transcription factor decoys, DNA oligonucleotides bearing the STAT-1 recognition motif, and then SEB-PBMC-conditioned medium displayed a reduced STAT-1 signal on EMSA, yet this treatment did not prevent the drop in transepithelial resistance (measured in Ussing chambers) caused by SEB-PBMC-conditioned medium. In contrast, the phosphatidylinositol 3'-kinase (PI 3-K) inhibitor LY-294002 significantly reduced the drop in transepithelial resistance caused by SEB-PBMC-conditioned medium. Thus data are presented showing STAT-1 (+/-STAT-3) and PI 3-K activation in epithelial cells in response to immune mediators released by superantigen immune activation. Although the involvement of STAT-1/-3 in the control of barrier function remains a possibility, PI-3K has been identified as a regulator of T84 paracellular permeability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053007     DOI: 10.1152/ajpgi.2000.279.5.G1094

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  8 in total

Review 1.  Small bowel review: Normal physiology, part 2.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells.

Authors:  Moorthy Krishnan; Declan F McCole
Journal:  Ann N Y Acad Sci       Date:  2017-08-14       Impact factor: 5.691

3.  Enterohemorrhagic Escherichia coli O157:H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells.

Authors:  Peter J M Ceponis; Derek M McKay; Joyce C Y Ching; Perpetual Pereira; Philip M Sherman
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

4.  Mechanism of interferon-gamma-induced increase in T84 intestinal epithelial tight junction.

Authors:  Michel A Boivin; Praveen K Roy; Angela Bradley; John C Kennedy; Tuhama Rihani; Thomas Y Ma
Journal:  J Interferon Cytokine Res       Date:  2009-01       Impact factor: 2.607

5.  The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.

Authors:  Anica Sayoc-Becerra; Moorthy Krishnan; Shujun Fan; Jossue Jimenez; Rebecca Hernandez; Kyle Gibson; Reyna Preciado; Grant Butt; Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2020-02-11       Impact factor: 5.325

Review 6.  Staphylococcal enterotoxins.

Authors:  Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  Toxins (Basel)       Date:  2010-08-18       Impact factor: 4.546

7.  Microbial products induce claudin-2 to compromise gut epithelial barrier function.

Authors:  Xiaoyu Liu; Gui Yang; Xiao-Rui Geng; Yanjuan Cao; Na Li; Li Ma; Si Chen; Ping-Chang Yang; Zhigang Liu
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

Review 8.  Mechanism of cytokine modulation of epithelial tight junction barrier.

Authors:  Rana Al-Sadi; Michel Boivin; Thomas Ma
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.